Recognizing the different hemodialysis modalities;Reconocimiento de las distintas modalidades: De hemodiálisis

Nefrologia

Volumn 26, Issue SUPPL.8, 2006, Pages 22-33

  Alcazar R ^a   Maduell, F ^a   Marti A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEMODIAFILTRATION; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY;

HEMODIAFILTRATION; HUMANS; RENAL DIALYSIS;

EID: 38449109565     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Morbidity and mortality of renal dialysis. AnNIH Consensus Conference Statement. Ann Intern Med 121: 62-70, 1994.
2. Ceballos M, López-Revuelta K, Saracho R y cols.: Informe de diálisis y trasplante correspondiente al año 2002 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrología 25: 121-129, 2005.
3. Maduell CF.: Diálisis Adecuada. Nefrología 22: 111-114, 2002.
4. a Ed. Madrid: Elsevier Science ed, pp. 385-393.
5. Evaluación de los diferentes tipos de membranas de hemodiálisis. Ministerio de Sanidad y Consumo. Instituto de Salud Carlos III. Agencia de Evaluación de Tecnologías Sanitarias, junio de 1996.
6. Eknoyan G, Beck GJ, Cheung AK y cols.: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002.
7. Allon M, Depner TA, Radeva M y cols.: Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 14: 1863-1870, 2003.
8. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 3: 1227-1237, 1992.
9. Woods HF, Nandakumar M: Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 15 (S1): 36-42, 2000.
10. Chauveau P, Nguyen H, Combe C y cols.: Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 45: 565-571, 2005.
11. Locatelli F: Dose of dialysis, convection and haemodialysis patients outcome. What the HEMO study doesn't tell us: the European viewpoint. Nephrol Dial Transplant 18: 1061-1065, 2003.
12. Locatelli F, Hannedouche T, Jacobson S y cols.: The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial. J Nephrol 12: 85-88, 1999.
13. Locatelli F, Manzoni C, Di Filippo S: The importance of convective transport. Kidney Int 61 (S80), S115-S120, 2002.
14. Varela L, Ruano A: Efectividad y seguridad de las diferentes variantes de hemodiálisis y hemodiafiltración. Servicio Galego de Saúde, Axencia de Avaliación de Tecnologías Sanitarias de Galicia, avalia-t; 2005 Serie Avaliación de Tecnologías. Informe de availación: INF2005/03.
15. Maduell F: Hemodiafiltration. Hemodiálisis Int 9: 47-55, 2005.
16. Kannaiyan S, Rabindranath MBBS, Giovanni FM y cols.: Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: Systematic Review. Am J Kidney Dis 45: 437-447, 2005.
17. Bolasco P, Altieri P, Andrulli S y cols.: Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant 18 (S7): VII50-VII54, 2003.
18. Penne E, Blankestijn P, Bots M y cols.: Resolving controversies regarding hemodiafiltration versus hemodialysis: The Dutch Convective Transport Study. Semin Dial 18: 47-51, 2005.
19. Canaud B, Bragg-Gresham JL, Marshall MR y cols.: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006: (in press).
20. Jirka T, Cesare S, Di Benedetto, Chang MP, Ponce P, Richards N: The impact of on-line haemodiafiltración (HDF) on patient survival: Results from large network database. Nephrol Dial Transplant 20 (Supl. 5): v18-v19, 2005.
21. Maduell F: Hemodiálisis diaria. Nefrología 23: 291-294, 2003.
22. Lindsay R and the Daily/Nocturnal Dialysis Study Group: the London, Ontario, Daily/Nocturnal Hemodialysis Study. Semin Dial 17: 85-91, 2004.
23. Walsh, Culleton B, Tonelli M, Manns B: A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67: 1500-1508, 2005.
24. Pierratos A, McFarlane P, Chan CT: Quotidian dialysis - update 2005; Curr Opin Nephrol Hypertens 14: 119-124, 2005
25. Pierratos A: Daily nocturnal home hemodialysis. Kidney Int 65:1975-1986, 2004.
26. Nesrallah GE, Moist LM, Awaraji C, Lindsay RM: An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls. Semin Dial 17: 131-135, 2004.
27. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 62: 2216-2222, 2002.
28. Kroeker A, Clark WF, Heidenheim AP y cols.: An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 42: 49-55, 2003.
29. Schulman G: Daily Hemodialysis: The time has come. Am J Kidney Dis 45: 798-803, 2005.
30. Lindsay R: Daily hemodialysis: the time has come. Am J Kidney Dis 45: 793-797, 2005.
31. Lindsay RM, Nesrallah G, Suri R y cols.: Is more frequent hemodialysis beneficial and what is the evidence? Curr Opin Nephrol Hypertens 13: 631-635, 2004.
32. Van Biesen W, Vanholder R, Lamiere N: Dialysis strategies in critically ill acute renal failure patients. Curr Opin Crit Care 9: 491-495, 2003.
33. Subramanian S, Venkataraman R, Kelllum JA: influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int 62:1819-1823, 2002.
34. Jaber BL, Lau J, Schmid CH y cols.: Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: a meta-analysis. Clin Nephrol 57: 274-282, 2002.
35. Tonelli M, Manns B, Feller-Kopman D: Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40: 875-885, 2002.
36. Kellum JA; Angus DC, Johnson JP y cols.: continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28: 29-37, 2002.
37. Uehlinger DE, Jakob SM, Ferrari P: Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nehprol Dial Transplant. 20 Advance Access Publishe Online, May 10, 2005.
38. Manns B, Doig CJ, Lee H y cols.: Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 31: 449-455, 2003.
39. Pérez García R, González Parra E, Ceballos F: Guidelines for quality management of dialysis solutions. Nefrología 24 (Supl. 2): 1-42, 2004.
40. Chanard J, Brunois IP, Melin JP y cols.: Long-term results of dialysis therapy with a highly permeable membrane. Artif Organs 6: 261-266, 1982.
41. Locatelli F, Mastrangelo F, Redaelli B y cols.: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 50: 1293-1302, 1996.
42. Churchill DN, Taylor DW, Tomlinson CW y cols.: Effect of high-flux hemodialysis on cardiac structure and function among patients with end-stage renal failure. Nephron 65: 573-577, 1993.
43. House AA, Wells Ga, Donnelly JG y cols.: Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids. Nephrol Dial Transplant 15: 1029-1034, 2000.
44. Marcus RG, Cohl E, Uribarri J: Middle molecule clearance does not influence protein intake in hemodialysis patients. Am J Kidney Dis 31: 491-494, 1998.
45. Villaverde M, Pérez-García R, Verde E y cols.: La polisulfona de alta permeabilidad mejora la respuesta de la anemia a la eritropoyetina en hemodiálisis. Nefrología 19: 161-167, 1999.
46. Opatrny Jr K, Reischig T, Vienken J y cols.: Does treatment modalito have an impact on anemia in patients with chronic renal failure? Effect of lo2-and high-flux biocompatible dialysis. Artif Organs 26: 181-188, 2002.
47. Merello Godino JL, Rentero R, Orlandini G y cols.: Results from EuCliDR (European Clinical Dialysis Database): Impact of shifting treatment modality. Int J Artif Organs 25: 1049-1060, 2002.
48. Locatelli F, Andrulli S, Pecchin F y cols.: Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant 15: 1399-1409, 2000.
49. Kuchle C, Fricke H, Held E, Schiffl H: High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 16: 484-488, 1996.